ArticleTherapeutics and clinical risk management2015

Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.

Michele Jara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.